Lack of association between NOD2 3020InsC frameshift mutation and psoriasis

被引:41
作者
Nair, RP
Stuart, P
Ogura, Y
Inohara, N
Chia, NVC
Young, L
Henseler, T
Jenisch, S
Christophers, E
Voorhees, JJ
Nuñez, G
Elder, JT
机构
[1] Univ Michigan, Canc Ctr 3312, Dept Dermatol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[5] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany
[6] Univ Kiel, Dept Immunol, D-2300 Kiel, Germany
[7] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA
关键词
D O I
10.1046/j.0022-202x.2001.01620.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:1671 / 1672
页数:2
相关论文
共 22 条
[1]   Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].
Baert, FJ ;
D'Haens, GR ;
Peeters, M ;
Hiele, MI ;
Schaible, TF ;
Shealy, D ;
Geboes, K ;
Rutgeerts, PJ .
GASTROENTEROLOGY, 1999, 116 (01) :22-28
[2]   Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3 [J].
Balendran, N ;
Clough, RL ;
Arguello, JR ;
Barber, R ;
Veal, C ;
Jones, AB ;
Rosbotham, JL ;
Little, AM ;
Madrigal, A ;
Barker, JNWN ;
Powris, SH ;
Trembath, RC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) :322-328
[3]   Advances in the search for psoriasis susceptibility genes [J].
Capon, F ;
Dallapiccola, B ;
Novelli, G .
MOLECULAR GENETICS AND METABOLISM, 2000, 71 (1-2) :250-255
[4]   Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].
Chaudhari, U ;
Romano, P ;
Mulcahy, LD ;
Dooley, LT ;
Baker, DG ;
Gottlieb, AB .
LANCET, 2001, 357 (9271) :1842-1847
[5]   ELEVATED TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) BIOLOGICAL-ACTIVITY IN PSORIATIC SKIN-LESIONS [J].
ETTEHADI, P ;
GREAVES, MW ;
WALLACH, D ;
ADERKA, D ;
CAMP, RDR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 96 (01) :146-151
[6]   SULFASALAZINE IMPROVES PSORIASIS - A DOUBLE-BLIND ANALYSIS [J].
GUPTA, AK ;
ELLIS, CN ;
SIEGEL, MT ;
DUELL, EA ;
GRIFFITHS, CEM ;
HAMILTON, TA ;
NICKOLOFF, BJ ;
VOORHEES, JJ .
ARCHIVES OF DERMATOLOGY, 1990, 126 (04) :487-493
[7]   Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations [J].
Hampe, J ;
Cuthbert, A ;
Croucher, PJP ;
Mirza, MM ;
Mascheretti, S ;
Fisher, S ;
Frenzel, H ;
King, K ;
Hasselmeyer, A ;
MacPherson, AJS ;
Bridger, S ;
van Deventer, S ;
Forbes, A ;
Nikolaus, S ;
Lennard-Jones, JE ;
Foelsch, UR ;
Krawczak, M ;
Lewis, C ;
Schreiber, S ;
Mathew, CG .
LANCET, 2001, 357 (9272) :1925-1928
[8]   THE TNF RECEPTOR 1-ASSOCIATED PROTEIN TRADD SIGNALS CELL-DEATH AND NF-KAPPA-B ACTIVATION [J].
HSU, HL ;
XIONG, J ;
GOEDDEL, DV .
CELL, 1995, 81 (04) :495-504
[9]   Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease [J].
Hugot, JP ;
Chamaillard, M ;
Zouali, H ;
Lesage, S ;
Cézard, JP ;
Belaiche, J ;
Almer, S ;
Tysk, C ;
O'Morain, CA ;
Gassull, M ;
Binder, V ;
Finkel, Y ;
Cortot, A ;
Modigliani, R ;
Laurent-Puig, P ;
Gower-Rousseau, C ;
Macry, J ;
Colombel, JF ;
Sahbatou, M ;
Thomas, G .
NATURE, 2001, 411 (6837) :599-603
[10]   GENETIC DISSECTION OF COMPLEX TRAITS - GUIDELINES FOR INTERPRETING AND REPORTING LINKAGE RESULTS [J].
LANDER, E ;
KRUGLYAK, L .
NATURE GENETICS, 1995, 11 (03) :241-247